Evidence & regulatory context
- Mechanism
- CHEMBL NOT QUERIED as a single entity: the therapy is a MULTI-COMPONENT flavonoid fraction from a crude botanical (five named constituents, one of them a previously undescribed flavonol glycoside), so no single ChEMBL drug entity can represent it.
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseChemical/toxinMale
Model: Carbon tetrachloride-induced acute hepatotoxicity
Flavonoid treatment prevented the biochemical changes induced by carbon tetrachloride, with compounds 1, 4 and 5 showing hepatoprotection comparable with silymarin.
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
